Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Priscilla K, Yen"'
Autor:
Jeffrey R, Curtis, Bradley, Stolshek, Paul, Emery, Boulos, Haraoui, Elaine, Karis, Greg, Kricorian, David H, Collier, Priscilla K, Yen, Vivian P, Bykerk
Publikováno v:
JCR: Journal of Clinical Rheumatology. 29:16-22
The effect of treatment withdrawal on patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) whose disease is in sustained remission has not been well described. This analysis aimed to compare PRO changes in patients with RA foll
Autor:
Priscilla K Yen, Elaine Karis, Jeffrey R. Curtis, Vivian P. Bykerk, Paul Emery, Greg Kricorian, Boulos Haraoui, James B. Chung
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective Patients with rheumatoid arthritis (RA) in whom remission is achieved following combination therapy with methotrexate plus etanercept face an ongoing medication burden. This study was undertaken to investigate whether sustained remission ac
Autor:
Jeffrey R. Curtis, Paul Emery, Greg Kricorian, Priscilla K. Yen, David H. Collier, Vivian Bykerk, Boulos Haraoui
Publikováno v:
The Journal of Rheumatology. :jrheum.2022-1008
ObjectiveSome patients with rheumatoid arthritis (RA) who persist in remission may decide to stop their therapy. We evaluated baseline characteristics associated with remaining in remission or low disease activity (LDA) following medication withdrawa
Publikováno v:
Arthritis & Rheumatology. 73:1771-1772
Autor:
David H. Collier, Philip S. Helliwell, Lyrica Liu, Leonieke J J van Mens, Alexis Ogdie, Vibeke Strand, Philip J. Mease, Laura C. Coates, Priscilla K Yen, Dafna D. Gladman, James B. Chung, Joseph F. Merola, Gregory Kricorian
Publikováno v:
Rheumatology (Oxford, England)
Objectives To examine which composite measures are most sensitive to change when measuring psoriatic arthritis (PsA) disease activity, analyses compared the responsiveness of composite measures used in a 48-week randomized, controlled trial of MTX an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e437b7323969be83fae7b7caa6eed938
https://doi.org/10.1093/rheumatology/keaa271
https://doi.org/10.1093/rheumatology/keaa271
Autor:
Shehnaz K. Hussain, Marta Epeldegui, Anne F. Rositch, Yu Guo, Joseph B. Margolick, Steven M. Wolinsky, Priscilla K. Yen, Gordana Halec, William G. Cumberland, Larry Magpantay, Bernard J.C. Macatangay, Otoniel Martinez-Maza
Publikováno v:
AIDS (London, England), vol 32, iss 7
Background Chronic immune activation is a harbinger of AIDS-associated non-Hodgkin lymphoma (AIDS-NHL), yet the underlying basis is unclear. Microbial translocation, the passage of microbial components from the gastrointestinal tract into the systemi
Autor:
John Boscardin, Hugh F. Alley, S. Marlene Grenon, Karen Chong, Christopher D. Owens, Matthew Spite, Emily V. Nosova, Priscilla K. Yen, Jason Hellmann, Sandra Perez, Michael S. Conte, Millie Hughes-Fulford
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Patients with peripheral artery disease ( PAD ) experience significant morbidity and mortality. The OMEGA ‐ PAD I Trial, a randomized, double‐blinded, placebo‐controlled trial, addressed the hypothesis that short‐duration, high‐d
Autor:
Michael S. Conte, S. Marlene Grenon, Christopher D. Owens, Jason Hellmann, Priscilla K. Yen, Hugh F. Alley, Karen C. Chong, Matthew Spite, Emily V. Nosova, Eveline O. Stock, Alex Quinn
Publikováno v:
The Journal of surgical research. 190(2)
Background Sedentarism, also termed physical inactivity, is an independent risk factor for cardiovascular diseases. Mechanisms thought to be involved include insulin resistance, dyslipidemia, hypertension, and increased inflammation. It is unknown wh
Autor:
Hugh F. Alley, Millie Hughes-Fulford, Priscilla K. Yen, S. Marlene Grenon, Karen Chong, William H. Harris, Christopher D. Owens, Michael S. Conte
Publikováno v:
Vascular medicine (London, England). 18(5)
Despite current consensus guidelines recommending intensive cardiovascular risk factor management for peripheral artery disease (PAD), patients suffering from PAD continue to experience significant morbidity and mortality. This excess morbid burden i